# FDA 483 - Charles River Laboratories, Inc. - March 21, 2025

Source: https://www.keypedia.com/records/483/charles-river-laboratories-inc/9be60eba-6ad6-42ac-96d9-d1ebdf6c2f11

> FDA 483 for Charles River Laboratories, Inc. on March 21, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Charles River Laboratories, Inc.
- Inspection Date: 2025-03-21
- Product Type: other
- Office Name: San Francisco District Office
- Summary: An FDA inspection of Charles River Laboratories, Inc. in Reno, NV, a nonclinical laboratory, revealed significant deficiencies in their study documentation and reporting practices. The firm failed to accurately record experimental data, ensure protocols contained all necessary details, and include complete descriptions of methods and test systems in final study reports. These issues suggest a lack of adherence to Good Laboratory Practice regulations.

## Related Officers

- [Audrey J. Yarbrough](https://www.keypedia.com/people/audrey-j-yarbrough/1bab3d1a-3246-451e-96fb-4ce52185e850)
- [Samson O. Oluseye](https://www.keypedia.com/people/samson-o-oluseye/bfe102f5-25cb-4ed9-9e69-2ec5ec0a047f)

Company: https://www.keypedia.com/companies/charles-river-laboratories-inc/81653ca6-9950-449f-a0b7-11d747b40a32

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df